- Atorvastatin Metabolite Pattern in Skeletal Muscle and Blood from Patients with Coronary Heart Disease and Statin-Associated Muscle Symptoms. Clinical Pharmacology and Therapeutics 2023.
- Barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial – a qualitative study. Frontiers in Psychology vol 14, 2023
- Risk of recurrent cardiovascular events in coronary artery disease patients with Type D personality. Frontiers in Psychology, vol 14, 2023
- Psychiatric disorders, rumination, and metacognitions in patients with type D personality and coronary heart disease, Nordic Journal of Psychiatry 2023
- Achieving the unachievable: How to optimize lipid lowering therapy in survivors of acute myocardial infarction. Polish Heart Journal 2023.
- Individualisert risikoreduksjon. 2021 Guidelines in CVD prevention. Hjerteforum 2023 (#Referater, s. 90-93)
- Plasma concentration of atorvastatin metabolites correlates with low-densitylipoprotein cholesterol reduction in patients with coronary heart disease. Pharmacology Research & Perspectives 2023
- Insomnia was associated with increased risk of recurrent cardiovascular events in coronary heart disease patients. ESC Preventive Cardiology Congress, Malaga 13-15 Mai 2023. Vitenskapelig foredrag av Lars Aastebøl Frøjd, John Munkhaugen mfl.
- Validation of a novel direct method to determine reduced adherence to atorvastatin therapy. ESC Preventive Cardiology Congress, Malaga 13-15 Mai 2023. Vitenskapelig foredrag av John Munkaugen
- Atorvastatin lactone/acid ratios are promising biomarkers for statin dependent muscular side effects in patients with coronary heart disease. ESC Preventive Cardiology Congress, Malaga 13-15 Mai 2023. Vitenskapelig foredrag av Trine Lauritzen, John Munkhaugen mfl.
- Predictors of health-related quality of life in outpatients with coronary heart disease. Frontiers in Psychlogy 2023
- Plasma-Metanephrines in Patients with Autoimmune Addison’s Disease with and without Residual Adrenocortical Function. Journal of Clinical Medicine 2023
